Clinical trials
Recruiting Adenocarcinoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 2 |
| European Institute of Oncology | 2 |
| AstraZeneca | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Institut Claudius Regaud | 1 |
| National Cancer Institute, Naples | 1 |
| Turning Point Therapeutics, Inc. | 1 |
| University of Milano Bicocca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 10 |
| Prostatic Neoplasms | 4 |
| Carcinoma, Neuroendocrine | 2 |
| Neoplasms | 2 |
| Neuroendocrine Tumors | 2 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Adenosquamous | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.